Grifols Celebrates World Hemophilia Day with Donation of Coagulation Medicines to the World Federation of Hemophilia
PR Newswire - Thu Apr 17, 7:47AM CDT
Grifols, S.A. (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) today announced that it will donate up to 20 million units of coagulation therapies in each of the next three (3) years to the World Federation of Hemophilia (WFH). Grifols has been a proud supporter of the WFH and its noble efforts for nearly a decade - and this unprecedented product donation represents its largest commitment to date. According to the WFH, this donation of blood clotting factor products will secure an average of 40,000 doses to treat approximately 10,000 patients in developing countries worldwide through 2017, where access to adequate treatment is often lacking or absent.
Fluor-Designed and Built Plasma Fractionation Facility Awarded ISPE 2014 Facility of the Year for Project Execution
Business Wire - Thu Apr 10, 3:37PM CDT
Fluor Corporation (NYSE: FLR) announced today that Grifols' North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical Engineering (ISPE) 2014 Facility of the Year for Project Execution.
Annual Report for 2013 on Form 20-F filed with the SEC on April 4, 2014
PR Newswire - Fri Apr 04, 10:54AM CDT
Grifols, S.A. ("Grifols"
Eagle Capital Growth Fund announces distribution of USD1.02 per share for year-end
M2 - Tue Dec 03, 3:16AM CST
Closed-end investment company Eagle Capital Growth Fund Inc (NYSE MKT:GRF) on Monday declared a year-end cash distribution of USD1.02 per share.
Eagle Capital Growth Fund Declares Year-End Distribution of $1.02 Per Share
Business Wire - Mon Dec 02, 3:00PM CST
The Eagle Capital Growth Fund, Inc. ("Fund"